Lucid Diagnostics (LUCD) EBITDA Margin Growth (1y) (2022 - 2026)
Lucid Diagnostics (LUCD) EBITDA Margin Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | -497.00 |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 670.00 |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 301.00 |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 546.00 |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 264.00 |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 595.00 |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 89.00 |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | -247.00 |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 146.00 |
| 10 | Lucid Diagnostics | 176.20 Mn | 142.80 Mn | 55,000.00 | 12,545.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12,545.00 |
| Mar 31, 2026 | 57,625.00 |
| Dec 31, 2025 | 9,852.00 |
| Sep 30, 2025 | 2,677.00 |
| Jun 30, 2025 | 19,805.00 |
| Mar 31, 2025 | -42,997.00 |
| Dec 31, 2024 | 6,742.00 |
| Sep 30, 2024 | 42,342.00 |
| Jun 30, 2024 | 613,881.00 |
| Mar 31, 2024 | 213,197.00 |
| Dec 31, 2023 | 1.23 Mn |
| Sep 30, 2023 | 1.75 Mn |
| Mar 31, 2023 | 328,250.00 |
| Dec 31, 2022 | -962,354.00 |
| Sep 30, 2022 | -1.57 Mn |